Education
About Us
Working with TipRanks
Follow Us
OncoZenge AB (SE:ONCOZ)
:ONCOZ
Total Valuation
OncoZenge AB has a market cap or net worth of kr71.96M. The enterprise value is kr70.26M.
Market Capkr71.96M
Enterprise Valuekr70.26M
Share Statistics
OncoZenge AB has 12,647,174 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,647,174
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
OncoZenge AB’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -87.29%.
Return on Equity (ROE)-0.87
Return on Assets (ROA)-0.76
Return on Invested Capital (ROIC)-87.29%
Return on Capital Employed (ROCE)-0.87
Revenue Per Employee1.00K
Profits Per Employee-8.69M
Employee Count1
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OncoZenge AB is ―. OncoZenge AB’s PEG ratio is 0.11.
PE Ratio―
PS Ratio43924.69
PB Ratio4.41
Price to Fair Value4.41
Price to FCF-5.01
Price to Operating Cash Flow-9.88
PEG Ratio0.11
Income Statement
In the last 12 months, OncoZenge AB had revenue of 1.00K and earned -8.69M in profits. Earnings per share was -0.74.
Revenue1.00K
Gross Profit1.00K
Operating Income-8.69M
Pretax Income-8.69M
Net Income-8.69M
EBITDA-8.69M
Earnings Per Share (EPS)-0.74
Cash Flow
In the last 12 months, operating cash flow was -6.01M and capital expenditures 0.00, giving a free cash flow of -6.01M billion.
Operating Cash Flow-6.01M
Free Cash Flow-6.01M
Free Cash Flow per Share-0.48
Dividends & Yields
OncoZenge AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.97
52-Week Price Change-30.76%
50-Day Moving Average5.82
200-Day Moving Average5.83
Relative Strength Index (RSI)58.75
Average Volume (3m)35.75K
Important Dates
OncoZenge AB upcoming earnings date is Feb 18, 2026, TBA (Confirmed).
Last Earnings DateOct 30, 2025
Next Earnings DateFeb 18, 2026
Ex-Dividend Date―
Financial Position
OncoZenge AB as a current ratio of 3.09, with Debt / Equity ratio of 0.00%
Current Ratio3.09
Quick Ratio3.09
Debt to Market Cap0.00
Net Debt to EBITDA0.44
Interest Coverage Ratio0.00
Taxes
In the past 12 months, OncoZenge AB has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
OncoZenge AB EV to EBITDA ratio is -4.61, with an EV/FCF ratio of -4.57.
EV to Sales40.06K
EV to EBITDA-4.61
EV to Free Cash Flow-4.57
EV to Operating Cash Flow-4.57
Balance Sheet
OncoZenge AB has kr1.56M in cash and marketable securities with kr0.00 in debt, giving a net cash position of kr1.56M billion.
Cash & Marketable Securitieskr1.56M
Total Debtkr0.00
Net Cashkr1.56M
Net Cash Per Sharekr0.12
Tangible Book Value Per Sharekr0.26
Margins
Gross margin is 100.00%, with operating margin of -868500.00%, and net profit margin of -868800.00%.
Gross Margin100.00%
Operating Margin-868500.00%
Pretax Margin-868800.00%
Net Profit Margin-868800.00%
EBITDA Margin-868500.00%
EBIT Margin-868500.00%
Analyst Forecast
The average price target for OncoZenge AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast20.55%